Patents by Inventor Juliana Cano-Mejia

Juliana Cano-Mejia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
    Patent number: 11931465
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: March 19, 2024
    Assignee: Children's National Medical Center
    Inventors: Rohan Fernandes, Raymond W. Sze, Conrad Russell Y. Cruz, Anthony D. Sandler, Catherine M. Bollard, Elizabeth E. Sweeney, Juliana Cano-Mejia, Rachel Burga, Matthieu F. Dumont
  • Prussian blue nanoparticles functionalized with immune signals and applications thereof
    Patent number: 11672861
    Abstract: Biofunctionalized nanocomposites comprised of a core nanoparticle formed of Prussian blue materials, a shell obtained by partially or completely encapsulating the Prussian blue core with a biocompatible coating, and at least one biomolecule attached to, or absorbed to, the biocompatible coating and uses thereof.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: June 13, 2023
    Assignee: The George Washington University
    Inventors: Rohan Fernandes, Elizabeth Sweeney, Juliana Cano-Mejia
  • FUNCTIONALIZED PRUSSIAN BLUE NANOPARTICLES, COMBINATION PRUSSIAN BLUE NANOPARTICLE-BASED NANO-IMMUNOTHERAPY AND APPLICATIONS THEREOF
    Publication number: 20200163899
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Application
    Filed: March 8, 2017
    Publication date: May 28, 2020
    Applicant: Children's National Medical Center
    Inventors: Rohan FERNANDES, Raymond W. SZE, Conrad Russell Y. CRUZ, Anthony D. SANDLER, Catherine M. BOLLARD, Elizabeth E. SWEENEY, Juliana CANO-MEJIA, Rachel BURGA, Mathieu F. DUMONT
  • PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZED WITH IMMUNE SIGNALS AND APPLICATIONS THEREOF
    Publication number: 20200114005
    Abstract: Biofunctionalized nanocomposites comprised of a core nanoparticle formed of Prussian blue materials, a shell obtained by partially or completely encapsulating the Prussian blue core with a biocompatible coating, and at least one biomolecule attached to, or absorbed to, the biocompatible coating and uses thereof.
    Type: Application
    Filed: March 19, 2019
    Publication date: April 16, 2020
    Inventors: Rohan Fernandes, Elizabeth Sweeny, Juliana Cano-Mejia